SEC Tracker
Get the app

Compass Therapeutics CMPX

Compass Therapeutics: quarterly report

Form
10-Q
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Compass Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Ocugen OCGN public float $279M, Jun 30, 2025
  2. Humacyte HUMA public float $280M, Jun 30, 2025
  3. Voyager Acquisition Corp./Cayman Islands VACH public float $270M, Dec 31, 2025
  4. Sana Biotechnology SANA public float $295M, Jun 30, 2025
  5. DBV Technologies DBVT public float $251M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.